A clinical trial to study the effect of the drug Kamalaiku kashayam in patients having Vali manjal noi(Fatty Liver Disease)

Phase 2 Non randomized open clinical evaluation of siddha medicine Kamalaiku kashayam for the management of Vali manjal noi(Fatty Liver Disease)

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2021/10/037674

Enrollment

Registered

2021-10-29

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E116- Type 2 diabetes mellitus with other specified complications

Interventions

Intervention1: Kamalaiku kashayam: 30ml ,twice a day for 30 days Control Intervention1: Nil: Nil

Eligibility

Inclusion criteria

Inclusion criteria: Subject within 20-60years, Grade 2 & Grade 1 fatty liver in USG abdomen Metabolic syndrome(Type 2 Diabetes mellitus,Obesity) Dyslipidemia

Exclusion criteria

Exclusion criteria: Cirrhosis HCC Alcoholic fatty liver Portal hypertension Hepatitis (HBV,HCV infection) Hepatosplenomegaly Cholecystitis

Design outcomes

Primary

Measure	Time frame
It is mainly assessed by reduction in the clinical symptoms of abdominal discomfort, fat deposition, fatigue and abdominal painTimepoint: 90days	—

Secondary

Measure	Time frame
By comparing the fat deposition changes assessed by USG abdomen Grade 2 to Grade 1, Grade 1 to normal in liver USG study before and after treatment.Timepoint: 30days	—

Countries

India

Contacts

Public ContactDrMenaka R

Government Siddha Medical College

rangasamymenaka75@gmail.com9444669661

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026